Motus GI Announces DDW 2023 Clinical Study Presentation Showing Pure-Vu EVS Drove a 33% Hospital-Wide Improvement in Incomplete Bowel Prep Rate at Minneapolis VA Medical Center

Read Release

Motus GI Reports First Quarter 2023 Financial Results and Provides Corporate Update

Read Release

Motus GI Announces Executive Leadership Restructuring and Additional Cost Saving Initiatives to Support Near-Term Milestones

Read Release

Motus GI Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

Read Release

Motus GI Announces Exploration of Strategic Alternatives to Enhance Shareholder Value and Announces Restructuring Plan

Read Release

Motus GI Announces Improvement of Pure-Vu® EVS System for Use in Upper Gastrointestinal (GI) Bleeding Procedures Following Successful Pre-Clinical Tests

Read Release

Motus GI Reports Third Quarter 2022 Financial Results and Provides Business Update

Read Release

Motus GI to Release Third Quarter Results and Provide a Business Update on November 14

Read Release

Motus GI Announces Positive Clinical Data for Pure-Vu EVS in Three Poster Presentations at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting

Read Release